|
|
Previous Article | Table of Contents | Next Article 
Blood, Vol. 94 No. 7 (October 1), 1999:
pp. 2445-2451
p15INK4B CpG Island Methylation in Primary
Acute Leukemia Is Heterogeneous and Suggests Density as a Critical
Factor for Transcriptional Silencing
Elizabeth E. Cameron,
Stephen B. Baylin, and
James G. Herman
From The Oncology Center, Department of Medicine and the Predoctoral
Training Program in Human Genetics, The Johns Hopkins University School
of Medicine, Baltimore, MD.
The promoter region of the cyclin-dependent kinase inhibitor
p15INK4B contains a CpG island that is
hypermethylated in many hematologic malignancies. To explore the
relationship between patterns of methylation and gene transcription, we
used bisulfite genomic sequencing to obtain a detailed analysis of
methylation in acute leukemia, leukemia cell lines, and normal
lymphocytes. The entire CpG island region of p15 was largely
devoid of methylation in normal lymphocytes, but methylation of varying
density was found in primary acute leukemia. Methylation density was
generally conserved between the alleles from each sample, but marked
heterogeneity for the specific CpG sites methylated was observed.
Patterns of methylation were compared and expression assessed with
reverse-transcriptase polymerase chain reaction (RT-PCR). The density
of methylation within the CpG island, and not any specific location,
correlates best with transcriptional loss. Leukemias with methylation
of approximately 40% of the CpG dinucleotides on each allele had complete gene silencing, with variable, but diminished expression with
less dense CpG island methylation. Our results suggest that the
transcriptional silencing of p15 in conjunction with aberrant hypermethylation is best understood as an evolutionary process that
involves progressively increasing methylation of the entire p15
CpG island.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Y. Ye, M. A. McDevitt, M. Guo, W. Zhang, O. Galm, S. D. Gore, J. E. Karp, J. P. Maciejewski, J. Kowalski, H.-L. Tsai, et al.
Progressive Chromatin Repression and Promoter Methylation of CTNNA1 Associated with Advanced Myeloid Malignancies
Cancer Res.,
November 1, 2009;
69(21):
8482 - 8490.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. E. Fandy, J. G. Herman, P. Kerns, A. Jiemjit, E. A. Sugar, S.-H. Choi, A. S. Yang, T. Aucott, T. Dauses, R. Odchimar-Reissig, et al.
Early epigenetic changes and DNA damage do not predict clinical response in an overlapping schedule of 5-azacytidine and entinostat in patients with myeloid malignancies
Blood,
September 24, 2009;
114(13):
2764 - 2773.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. E. Varley, D. G. Mutch, T. B. Edmonston, P. J. Goodfellow, and R. D. Mitra
Intra-tumor heterogeneity of MLH1 promoter methylation revealed by deep single molecule bisulfite sequencing
Nucleic Acids Res.,
August 1, 2009;
37(14):
4603 - 4612.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S Uccella, R Cerutti, C Placidi, S Marchet, I Carnevali, B Bernasconi, I Proserpio, G Pinotti, M G Tibiletti, D Furlan, et al.
MGMT methylation in diffuse large B-cell lymphoma: validation of quantitative methylation-specific PCR and comparison with MGMT protein expression
J. Clin. Pathol.,
August 1, 2009;
62(8):
715 - 723.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Figueroa, B. J. Wouters, L. Skrabanek, J. Glass, Y. Li, C. A. J. Erpelinck-Verschueren, A. W. Langerak, B. Lowenberg, M. Fazzari, J. M. Greally, et al.
Genome-wide epigenetic analysis delineates a biologically distinct immature acute leukemia with myeloid/T-lymphoid features
Blood,
March 19, 2009;
113(12):
2795 - 2804.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Balic, M. Pichler, J. Strutz, E. Heitzer, C. Ausch, H. Samonigg, R. J. Cote, and N. Dandachi
High Quality Assessment of DNA Methylation in Archival Tissues from Colorectal Cancer Patients Using Quantitative High-Resolution Melting Analysis
J. Mol. Diagn.,
March 1, 2009;
11(2):
102 - 108.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Yi, H.-C. Tsai, S. C. Glockner, S. Lin, J. E. Ohm, H. Easwaran, C. D. James, J. F. Costello, G. Riggins, C. G. Eberhart, et al.
Abnormal DNA Methylation of CD133 in Colorectal and Glioblastoma Tumors
Cancer Res.,
October 1, 2008;
68(19):
8094 - 8103.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. S. Kristensen, T. Mikeska, M. Krypuy, and A. Dobrovic
Sensitive Melting Analysis after Real Time- Methylation Specific PCR (SMART-MSP): high-throughput and probe-free quantitative DNA methylation detection
Nucleic Acids Res.,
April 1, 2008;
36(7):
e42 - e42.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Lavon, D. Zrihan, B. Zelikovitch, Y. Fellig, D. Fuchs, D. Soffer, and T. Siegal
Longitudinal Assessment of Genetic and Epigenetic Markers in Oligodendrogliomas
Clin. Cancer Res.,
March 1, 2007;
13(5):
1429 - 1437.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Markus, M. T. Garin, J. Bies, N. Galili, A. Raza, M. J. Thirman, M. M. Le Beau, J. D. Rowley, P. P. Liu, and L. Wolff
Methylation-Independent Silencing of the Tumor Suppressor INK4b (p15) by CBF{beta}-SMMHC in Acute Myelogenous Leukemia with inv(16)
Cancer Res.,
February 1, 2007;
67(3):
992 - 1000.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Agrawal, M. Unterberg, S. Koschmieder, U. zur Stadt, U. Brunnberg, W. Verbeek, T. Buchner, W. E. Berdel, H. Serve, and C. Muller-Tidow
DNA Methylation of Tumor Suppressor Genes in Clinical Remission Predicts the Relapse Risk in Acute Myeloid Leukemia
Cancer Res.,
February 1, 2007;
67(3):
1370 - 1377.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Raza, F. Z. Raza, N. Galili, H. M. Kantarjian, Y. Oki, and J.-P. Issa
Low-dose decitabine and high-risk MDS
Blood,
December 15, 2006;
108(13):
4291 - 4292.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Gebhard, L. Schwarzfischer, T. H. Pham, R. Andreesen, A. Mackensen, and M. Rehli
Rapid and sensitive detection of CpG-methylation using methyl-binding (MB)-PCR
Nucleic Acids Res.,
July 5, 2006;
34(11):
e82 - e82.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. D. Gore, S. Baylin, E. Sugar, H. Carraway, C. B. Miller, M. Carducci, M. Grever, O. Galm, T. Dauses, J. E. Karp, et al.
Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasms.
Cancer Res.,
June 15, 2006;
66(12):
6361 - 6369.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.-J. Kim, E.-J. Kim, P. Jeong, C. Quan, J. Kim, Q.-L. Li, J.-O. Yang, Y. Ito, and S.-C. Bae
RUNX3 Inactivation by Point Mutations and Aberrant DNA Methylation in Bladder Tumors
Cancer Res.,
October 15, 2005;
65(20):
9347 - 9354.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Brell, A. Tortosa, E. Verger, J. M. Gil, N. Vinolas, S. Villa, J. J. Acebes, L. Caral, T. Pujol, I. Ferrer, et al.
Prognostic Significance of O6-Methylguanine-DNA Methyltransferase Determined by Promoter Hypermethylation and Immunohistochemical Expression in Anaplastic Gliomas
Clin. Cancer Res.,
July 15, 2005;
11(14):
5167 - 5174.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Raval, D. M. Lucas, J. J. Matkovic, K. L. Bennett, S. Liyanarachchi, D. C. Young, L. Rassenti, T. J. Kipps, M. R. Grever, J. C. Byrd, et al.
TWIST2 Demonstrates Differential Methylation in Immunoglobulin Variable Heavy Chain Mutated and Unmutated Chronic Lymphocytic Leukemia
J. Clin. Oncol.,
June 10, 2005;
23(17):
3877 - 3885.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. N. Bhalla
Epigenetic and Chromatin Modifiers As Targeted Therapy of Hematologic Malignancies
J. Clin. Oncol.,
June 10, 2005;
23(17):
3971 - 3993.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. R. Hodge, B. Peng, J. C. Cherry, E. M. Hurt, S. D. Fox, J. A. Kelley, D. J. Munroe, and W. L. Farrar
Interleukin 6 Supports the Maintenance of p53 Tumor Suppressor Gene Promoter Methylation
Cancer Res.,
June 1, 2005;
65(11):
4673 - 4682.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.G. HERMAN
Epigenetic Changes in Cancer and Preneoplasia
Cold Spring Harb Symp Quant Biol,
January 1, 2005;
70(0):
329 - 333.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Akiyama, N. Watkins, H. Suzuki, K.-W. Jair, M. van Engeland, M. Esteller, H. Sakai, C.-Y. Ren, Y. Yuasa, J. G. Herman, et al.
GATA-4 and GATA-5 Transcription Factor Genes and Potential Downstream Antitumor Target Genes Are Epigenetically Silenced in Colorectal and Gastric Cancer
Mol. Cell. Biol.,
December 1, 2003;
23(23):
8429 - 8439.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. D. Carvin, R. D. Parr, and M. P. Kladde
Site-selective in vivo targeting of cytosine-5 DNA methylation by zinc-finger proteins
Nucleic Acids Res.,
November 15, 2003;
31(22):
6493 - 6501.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. S. Yan, H. Shi, F. Rahmatpanah, T. H-C. Hsiau, A. H-A. Hsiau, Y.-W. Leu, J. C. Liu, and T. H.-M. Huang
Differential Distribution of DNA Methylation within the RASSF1A CpG Island in Breast Cancer
Cancer Res.,
October 1, 2003;
63(19):
6178 - 6186.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. A. Yates, R. Burman, J. Simpson, O. N. Ponomoreva, M. J. Thayer, and M. S. Turker
Silencing of Mouse Aprt Is a Gradual Process in Differentiated Cells
Mol. Cell. Biol.,
July 1, 2003;
23(13):
4461 - 4470.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Bhatia, A. K Siraj, A. Hussain, R. Bu, and M. I Gutierrez
The Tumor Suppressor Gene 14-3-3{sigma} Is Commonly Methylated in Normal and Malignant Lymphoid Cells
Cancer Epidemiol. Biomarkers Prev.,
February 1, 2003;
12(2):
165 - 169.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Mufti, A. F. List, S. D. Gore, and A. Y.L. Ho
Myelodysplastic Syndrome
Hematology,
January 1, 2003;
2003(1):
176 - 199.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Lappalainen and M. Vihinen
Structural basis of ICF-causing mutations in the methyltransferase domain of DNMT3B
Protein Eng. Des. Sel.,
December 1, 2002;
15(12):
1005 - 1014.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Lehmann, G. Celikkaya, B. Hasemeier, F. Langer, and H. Kreipe
Promoter Hypermethylation of the Death-associated Protein Kinase Gene in Breast Cancer Is Associated with the Invasive Lobular Subtype
Cancer Res.,
November 15, 2002;
62(22):
6634 - 6638.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Daskalakis, T. T. Nguyen, C. Nguyen, P. Guldberg, G. Kohler, P. Wijermans, P. A. Jones, and M. Lubbert
Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2'-deoxycytidine (decitabine) treatment
Blood,
September 26, 2002;
100(8):
2957 - 2964.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Li, H. Nagai, T. Ohno, M. Yuge, S. Hatano, E. Ito, N. Mori, H. Saito, and T. Kinoshita
Aberrant DNA methylation of p57KIP2 gene in the promoter region in lymphoid malignancies of B-cell phenotype
Blood,
September 18, 2002;
100(7):
2572 - 2577.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Garcia, B. Martinez-Delgado, A. Cebrian, A. Martinez, J. Benitez, and C. Rivas
Different Incidence and Pattern of p15INK4b and p16INK4a Promoter Region Hypermethylation in Hodgkin's and CD30-Positive Non-Hodgkin's Lymphomas
Am. J. Pathol.,
September 1, 2002;
161(3):
1007 - 1013.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Garcia-Manero, J. Daniel, T. L. Smith, S. M. Kornblau, M.-S. Lee, H. M. Kantarjian, and J.-P. J. Issa
DNA Methylation of Multiple Promoter-associated CpG Islands in Adult Acute Lymphocytic Leukemia
Clin. Cancer Res.,
July 1, 2002;
8(7):
2217 - 2224.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Mertens, S. Wolf, P. Schroeter, C. Schaffner, H. Dohner, S. Stilgenbauer, and P. Lichter
Down-regulation of candidate tumor suppressor genes within chromosome band 13q14.3 is independent of the DNA methylation pattern in B-cell chronic lymphocytic leukemia
Blood,
May 13, 2002;
99(11):
4116 - 4121.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Worm, A. Aggerholm, and P. Guldberg
In-Tube DNA Methylation Profiling by Fluorescence Melting Curve Analysis
Clin. Chem.,
July 1, 2001;
47(7):
1183 - 1189.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Guillerm, E. Gyan, D. Wolowiec, T. Facon, H. Avet-Loiseau, K. Kuliczkowski, F. Bauters, P. Fenaux, and B. Quesnel
p16INK4a and p15INK4b gene methylations in plasma cells from monoclonal gammopathy of undetermined significance
Blood,
July 1, 2001;
98(1):
244 - 246.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. J. Rush, Z. Dai, D. J. Smiraglia, X. Gao, F. A. Wright, M. Fruhwald, J. F. Costello, W. A. Held, L. Yu, R. Krahe, et al.
Novel methylation targets in de novo acute myeloid leukemia with prevalence of chromosome 11 loci
Blood,
May 15, 2001;
97(10):
3226 - 3233.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-i. Mizuno, T. Chijiwa, T. Okamura, K. Akashi, Y. Fukumaki, Y. Niho, and H. Sasaki
Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia
Blood,
March 1, 2001;
97(5):
1172 - 1179.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kawakami, J. Brabender, R. V. Lord, S. Groshen, B. D. Greenwald, M. J. Krasna, J. Yin, A. S. Fleisher, J. M. Abraham, D. G. Beer, et al.
Hypermethylated APC DNA in Plasma and Prognosis of Patients With Esophageal Adenocarcinoma
J Natl Cancer Inst,
November 15, 2000;
92(22):
1805 - 1811.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Patel, C. H. Anna, J. F. Foley, P. S. Stockton, F. L. Tyson, J.C. Barrett, and T. R. Devereux
Hypermethylation of the p16 Ink4a promoter in B6C3F1 mouse primary lung adenocarcinomas and mouse lung cell lines
Carcinogenesis,
September 1, 2000;
21(9):
1691 - 1700.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Aggerholm, P. Hokland, P. Guldberg;, and J. G. Herman
DAP-kinase CpG island methylation in acute myeloid leukemia: methodology versus biology?
Blood,
May 1, 2000;
95(9):
2997 - 2999.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Lu, W.-C. Au, W.-S. Yeow, N. Hageman, and P. M. Pitha
Regulation of the Promoter Activity of Interferon Regulatory Factor-7 Gene. ACTIVATION BY INTERFERON AND SILENCING BY HYPERMETHYLATION
J. Biol. Chem.,
October 6, 2000;
275(41):
31805 - 31812.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Galm, M. R. Rountree, K. E. Bachman, K.-W. Jair, S. B. Baylin, and J. G. Herman
Enzymatic Regional Methylation Assay: A Novel Method to Quantify Regional CpG Methylation Density
Genome Res.,
January 1, 2002;
12(1):
153 - 157.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|